Physician profile
Blake E Leibowitz
NPI 1578012118
$1,380.16
in general payments reported to CMS, 2019-2025
8 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $670 · 2023: $319 · 2024: $171 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.94 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $558.60 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $227.36 | 2022-2024 | Saphnelo |
| Amgen INC. | $135.69 | 2022-2025 | Krystexxa |
| Janssen Scientific Affairs, LLC | $113.97 | 2022 | |
| Horizon Therapeutics Plc | $104.46 | 2022 | |
| Lilly USA, LLC | $103.84 | 2022-2025 | Zepbound |
| Janssen Biotech, INC. | $99.00 | 2025 | Tremfya |
| Ucb, INC. | $37.24 | 2023 | Cimzia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Leibowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.